Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Allscripts announces fourth quarter and 2016 full-year results
February 16, 2017 4:01 PM ESTFourth quarter revenue grows 23 and 24 percent, 2016 revenue grows 12 and 14 percent (GAAP and non-GAAP, respectively), year-over-yearRecord fourth quarter bookings of $406 million and all-time record annual bookings of $1.3 billion2016 operating cash flow grows 27 percent year-over-year, totaling $269 millionOutlook for 2017 anticipates 8-10 percent revenue and 10-15 percent EPS growth, respectively
CHICAGO, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) (Allscripts) announced its financial results for the three months and year ended December 31, 2016.
Fourth Quarter and Recent Business... More
